DD
Durga Devi Charllapally
About Durga Devi Charllapally
Data last updated:
Durga Devi Charllapally is an Additional Director at Maven Scientific Laboratories Private Limited (since 2022) and Additional Director at Veles Therapeutics Private Limited (since 2023). The companies operate in Research & Development. The largest current company by reported revenue is Maven Scientific Laboratories Private Limited at ₹88.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Maven Scientific Laboratories Private Limited U73100TG2020PTC142617 | Additional Director | 01 Apr 2022 | 2020 | ₹88.9 Lakh (FY 2025) | Active |
| Veles Therapeutics Private Limited U73100KA2022PTC163522 | Additional Director | 25 Aug 2023 | 2022 | Active |
Board colleagues of Durga Devi Charllapally
| Name | DIN | Company | Designation |
|---|---|---|---|
| Bhavani Shankar Goud Charllapally | 08826344 | Maven Scientific Laboratories Private Limited | Director |
| Aparna Nandavaram | 09666363 | Veles Therapeutics Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Durga Devi Charllapally
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Durga Devi Charllapally
Durga Devi Charllapally currently holds 2 directorships: Maven Scientific Laboratories Private Limited (Additional Director, since 01 Apr 2022, revenue ₹88.9 Lakh (FY 2025)); Veles Therapeutics Private Limited (Additional Director, since 25 Aug 2023).
Durga Devi Charllapally was first appointed on 01 Apr 2022 as Additional Director at Maven Scientific Laboratories Private Limited. The most recent appointment on record is 25 Aug 2023 at Veles Therapeutics Private Limited.
The current boards of Durga Devi Charllapally's companies include Bhavani Shankar Goud Charllapally (Maven Scientific Laboratories Private Limited), Aparna Nandavaram (Veles Therapeutics Private Limited).